Abivax SA American Depositary Shares (ABVX) Financials
Key financial figures for Abivax SA American Depositary Shares (Q2 2026), as reported in EUR.
Abivax S.A. reported revenue of 0.00 EUR for Q2 FY2026. The company posted a net loss of 117.4 million EUR, or -1.47 EUR per share. Free cash flow for the period was -52.1 million EUR. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Abivax S.A. are on the SentiSense financials page.
- Revenue
- EUR 0
- Net Income
- -EUR 117M
- EPS
- EUR -1.47
- Total Assets
- EUR 462M
- Operating Cash Flow
- -EUR 52M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | EUR 0 | -EUR 117M | -EUR 1.47 | -EUR 52M | |
| Q4 FY2025 | EUR 0 | -EUR 288M | -EUR 2.10 | ||
| Q2 FY2025 | EUR 0 | -EUR 48M | -EUR 1.59 | -EUR 33M | |
| Q4 FY2024 | EUR 0 | -EUR 52M | -EUR 1.50 | -EUR 33M | |
| Q2 FY2024 | EUR 0 | -EUR 39M | -EUR 0.65 | -EUR 51M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | EUR 0 | -EUR 336M | -EUR 4.65 | -EUR 156M | |
| FY2024 | EUR 0 | -EUR 176M | -EUR 2.80 | -EUR 155M | |
| FY2023 | EUR 0 | -EUR 148M | -EUR 3.43 | -EUR 100M |
Frequently asked questions
What was Abivax S.A.'s revenue last quarter?
Abivax S.A. reported revenue of 0.00 EUR for Q2 FY2026.
Is Abivax S.A. profitable?
Not in its most recent reported period. Abivax S.A. reported a net loss of 117.4 million EUR for Q2 FY2026.
How much free cash flow did Abivax S.A. generate?
Abivax S.A. generated free cash flow of -52.1 million EUR in Q2 FY2026, after capital expenditure.
Figures are as reported by the filer in EUR and are not converted to US dollars. The share price is quoted in US dollars, so the two are not directly comparable.
Full income statement, balance sheet and cash flow for Abivax SA American Depositary Shares on SentiSense, with up to forty quarters and twenty fiscal years of history.